117 related articles for article (PubMed ID: 11494542)
1. [The present state and problems of HCV blood screening system in blood products].
Yatsuhashi H; Yano M
Nihon Rinsho; 2001 Jul; 59(7):1303-7. PubMed ID: 11494542
[TBL] [Abstract][Full Text] [Related]
2. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing.
Murokawa H; Yoshikawa A; Ohnuma H; Iwata A; Katoh N; Miyamoto M; Mine H; Emura H; Tadokoro K;
Vox Sang; 2005 Jan; 88(1):10-6. PubMed ID: 15663717
[TBL] [Abstract][Full Text] [Related]
4. Status of NAT screening for HCV, HIV and HBV: experience in Japan.
Tomono T; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Murozuka T; Emura H; Doi Y; Mine H; Yokoyama S; Ohnuma H; Tanaka T; Yoshikawa A; Nishioka K;
Dev Biol (Basel); 2002; 108():29-39. PubMed ID: 12220140
[TBL] [Abstract][Full Text] [Related]
5. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
[TBL] [Abstract][Full Text] [Related]
6. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
7. First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays.
Kretzschmar E; Chudy M; Nübling CM; Ross RS; Kruse F; Trobisch H
Vox Sang; 2007 May; 92(4):297-301. PubMed ID: 17456153
[TBL] [Abstract][Full Text] [Related]
8. Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission.
Katayama K; Kumagai J; Komiya Y; Mizui M; Yugi H; Kishimoto S; Yamanaka R; Tamatsukuri S; Tomoguri T; Miyakawa Y; Tanaka J; Yoshizawa H
Intervirology; 2004; 47(1):57-64. PubMed ID: 15044837
[TBL] [Abstract][Full Text] [Related]
9. Screening of blood donations by hepatitis C virus polymerase chain reaction (HCV-PCR) improves safety of blood products by window period reduction.
Hitzler WE; Runkel S
Clin Lab; 2001; 47(5-6):219-22. PubMed ID: 11405599
[TBL] [Abstract][Full Text] [Related]
10. [Present status of transfusion-associated hepatitis C virus infection--efficiency after implementation of nucleic acid amplification testing].
Takahashi M; Muraoka M; Tadokoro K
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):267-71. PubMed ID: 15359805
[No Abstract] [Full Text] [Related]
11. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
[TBL] [Abstract][Full Text] [Related]
12. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
[TBL] [Abstract][Full Text] [Related]
13. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
[TBL] [Abstract][Full Text] [Related]
15. The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland.
Brojer E; Gronowska A; Medyńska J; Grabarczyk P; Mikulska M; Letowska M; Kryczka W; Gietka A
Transfusion; 2004 Dec; 44(12):1706-10. PubMed ID: 15584984
[TBL] [Abstract][Full Text] [Related]
16. [Serological and molecular markers of HCV infection in Polish blood donors].
Brojer E
Przegl Epidemiol; 2005; 59(2):511-7. PubMed ID: 16190561
[TBL] [Abstract][Full Text] [Related]
17. Screening of serologically negative plasma pools for hepatitis C virus by nucleic acid amplification testing in Croatia, 2001-2003.
Forcić D; Zgorelec R; Kosutić-Gulija T; Ivancić J; Baricević M; Lupret L; Mazuran R
Transfus Apher Sci; 2005 Oct; 33(2):175-9. PubMed ID: 16122985
[TBL] [Abstract][Full Text] [Related]
18. Experiences in HCV-NAT screening prior to releasing cellular components by the German Red Cross Blood Transfusion Service of Baden-Württemberg.
Cardoso MS; Koerner K; Hinz W; Lenz C; Prokein S; Rau B; Schwandt A; Kubanek B
Biologicals; 1999 Dec; 27(4):281-4. PubMed ID: 10686053
[TBL] [Abstract][Full Text] [Related]
19. Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing.
Jarvis LM; Dow BC; Cleland A; Davidson F; Lycett C; Morris K; Webb B; Jordan A; Petrik J
Vox Sang; 2005 Oct; 89(3):128-34. PubMed ID: 16146504
[TBL] [Abstract][Full Text] [Related]
20. [HCV genotypes in Polish blood donors in period 1995-2007].
Brojer E; Grabarczyk P; Kopacz A; Potepa A; Medyńska J; Smolarczyk-Wodzyńska J; Letowska M
Przegl Epidemiol; 2008; 62(1):163-9. PubMed ID: 18536240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
